چاپ صفحه |  صفحه نخست سامانه |  نویسندگان |  اطلاعات تفضیلی |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده | نفر چندم مقاله |
|---|---|
| رامین قاسمی شایان | اول |
| فخرالسادات سجادیان | دوم |
| عنوان | متن |
|---|---|
| کلمات کلیدی | Chemoprevention, drug development, translational biomarkers, malignant |
| خلاصه مقاله | Chemoprevention is the utilization of specialists to slow the movement of, switch, or restrain carcinogenesis. Chemopreventive specialists adjust disease chance at the sub-atomic, cell, tissue, and clinical levels. The systems of these specialists are characterized by exercises seen at the sub-atomic and cell levels, while chemopreventive adequacy is assessed at the tissue and clinical levels. The section talks about standards of atomic objective based chemopreventive medication revelation and early advancement of five prototypical operator classes that indicated critical chemopreventive action, and audits the method of reasoning for their turn of events. The section examines the particular classes to the all-inclusive statement of sub-atomic objective and observational based screening measures helpful for revelation and early advancement of applicant chemopreventive operators. The reason and strategies for the advancement of a successive medication improvement program, based on the balanced system based and exact specialist disclosure approach, are summed up. This program recognizes and assesses transitional biomarkers as substitute end focuses for malignant growth rate |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| Abstract paragoe congress.docx | 1399/03/20 | 12619 | دانلود |
| paragoe- Acceptance letter.pdf | 1399/03/20 | 871672 | دانلود |
| parag (1)- ketabche.pdf | 1399/03/20 | 191797 | دانلود |
